PolyNovo (ASX:PNV) has announced that Professor Toby Coates AO, the director of Beta Cell Technologies, has presented the results of the company's NovoSorb and its potential role in treating and managing Type 1 diabetes.
Latest News
New Stories
-
PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes
May 14, 2025 - - AusBiotech -
EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy
May 12, 2025 - - Latest News -
Australia gets a new minister for industry, innovation and science
May 12, 2025 - - Latest News -
PolyNovo announces TGA clearance for NovoSorb MTX and enters trading halt
May 12, 2025 - - Latest News -
Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells
May 12, 2025 - - Latest News -
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 - - Latest News -
Experienced industry executive appointed chair of Tryptamine Therapeutics
May 12, 2025 - - Latest News